Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Novartis ag symbols : Vcel save search
Regenerative Medicine Market Size to Hit USD 44.63 Billion by 2024, with at a 20.16% CAGR Over the Forecast Period | Brandessence Market Research
Published: 2023-09-26 (Crawled : 08:00) - prnewswire.com
NVSEF | News | $96.0 0.94% 6.88% 0
|
Health Technology
|
| O: -3.05%
H: 1.75%
C: 0.5%
SYK | $336.85 0.58% 0.93% 1.2M
|
Health Technology
|
| O: -0.92%
H: 0.24%
C: -3.93%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.07%
H: 0.46%
C: -0.31%
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
|
| O: -0.49%
H: 0.65%
C: -0.56%
ABBV | News | $167.8 -1.03% -0.02% 2.9M
|
Health Technology
|
| O: 1.16%
H: 0.13%
C: -0.32%
VCEL | $46.11 -0.67% -0.72% 200K
|
Health Technology
|
| O: 0.38%
H: 1.7%
C: -1.85%
BIIB | $201.99 4.56% 4.32% 420
|
Health Technology
|
| O: -0.02%
H: 1.37%
C: 1.21%
research market
Cell Therapy Market Value to Reach US$ 54.6 Bn by 2032, States TMR Study
Published: 2022-12-19 (Crawled : 13:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.0%
H: 0.09%
C: -0.32%
VCEL | $46.11 -0.67% -0.72% 200K
|
Health Technology
|
| O: -0.49%
H: 0.02%
C: -6.55%
therapy study market
Global $21.2 Bn Advanced Therapy Medicinal Products Market to 2028: Breakthrough Approvals of Tecartus and Abecma Post-approval of Zolgensma, Kymriah, and Yescarta have Bolstered Rapid Advancements
Published: 2021-09-23 (Crawled : 12:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.92%
H: 0.5%
C: 0.01%
BMY | $48.86 -0.27% 0.98% 14M
|
Health Technology
|
| O: 0.42%
H: 1.55%
C: 0.38%
VCEL | $46.11 -0.67% -0.72% 200K
|
Health Technology
|
| O: 0.86%
H: 2.12%
C: 1.89%
QURE | $4.56 -4.0% -3.94% 640K
|
Health Technology
|
| O: 0.5%
H: 0.58%
C: -5.62%
BLUE | $0.9229 -4.91% -4.66% 14K
|
Health Technology
|
| O: 1.11%
H: 2.8%
C: 2.53%
BIIB | $201.99 4.56% 4.32% 420
|
Health Technology
|
| O: 1.51%
H: 2.09%
C: -0.17%
therapy approval
Regenerative Medicine Market Research Report 2021-2030: Emerging Economies are Key Opportunity Areas for Market Players
Published: 2021-07-16 (Crawled : 16:00) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: -0.18%
H: 0.0%
C: 0.0%
SYK | $336.85 0.58% 0.93% 1.2M
|
Health Technology
|
| O: 0.1%
H: 0.34%
C: 0.11%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.84%
H: 0.05%
C: -0.35%
MDT | $80.38 -1.12% -0.03% 5M
|
Health Technology
|
| O: 0.23%
H: 0.41%
C: 0.12%
MMM | $92.02 -1.05% 0.17% 2.7M
|
Producer Manufacturing
|
| O: 0.26%
H: 0.04%
C: -1.85%
VCEL | $46.11 -0.67% -0.72% 200K
|
Health Technology
|
| O: 0.42%
H: 0.0%
C: 0.0%
IART | $29.38 -0.1% 900K
|
Health Technology
|
| O: 0.03%
H: 1.2%
C: 0.96%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.59%
H: 0.58%
C: -0.05%
research market
Advanced Therapy Medicinal Products Market Size Worth $21.2 Billion By 2028: Grand View Research, Inc.
Published: 2021-05-12 (Crawled : 08:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.63%
H: 0.58%
C: -0.44%
VCEL | $46.11 -0.67% -0.72% 200K
|
Health Technology
|
| O: -4.6%
H: 4.8%
C: -1.06%
BIIB | $201.99 4.56% 4.32% 420
|
Health Technology
|
| O: -0.44%
H: 1.27%
C: -1.14%
therapy research
Insights on the Advanced Therapy Medicinal Products Global Market to 2027 - Featuring Bluebird Bio, Celgene and Gilead Lifesciences Among Others
Published: 2021-04-26 (Crawled : 14:00) - prnewswire.com
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -0.17%
H: 0.11%
C: -0.35%
VCEL | $46.11 -0.67% -0.72% 200K
|
Health Technology
|
| O: 1.11%
H: 6.59%
C: 6.31%
QURE | $4.56 -4.0% -3.94% 640K
|
Health Technology
|
| O: 5.7%
H: 4.95%
C: 2.43%
BLUE | $0.9229 -4.91% -4.66% 14K
|
Health Technology
|
| O: 1.19%
H: 2.0%
C: 1.69%
therapy
Cell and Gene Therapy Drug Delivery Devices Market, 2030 - Market Opportunities in the Strong Pipeline of Cell and Gene Therapies
Published: 2021-03-30 (Crawled : 22:00) - prnewswire.com
PFE | News 4 | $26.27 -0.19% 0.19% 18M
|
Health Technology
|
| O: 0.11%
H: 0.77%
C: 0.22%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: -1.55%
H: 0.51%
C: -0.22%
BDX | $233.83 -0.23% 0.0% 6
|
Health Technology
|
| O: -0.01%
H: 0.25%
C: -0.82%
VCEL | $46.11 -0.67% -0.72% 200K
|
Health Technology
|
| O: 0.74%
H: 5.83%
C: 4.75%
QURE | $4.56 -4.0% -3.94% 640K
|
Health Technology
|
| O: -0.81%
H: 4.45%
C: 2.03%
ORTX | $16.7 0.0% 370K
|
Health Technology
|
| O: -0.7%
H: 4.08%
C: 2.25%
BLUE | $0.9229 -4.91% -4.66% 14K
|
Health Technology
|
| O: 0.66%
H: 5.38%
C: 4.65%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: -0.21%
H: 0.29%
C: -0.17%
gene therapies gene therapy therapy drug device drug delivery liver
Regenerative Medicine Market Revenue Worth $39,012 Million by 2030: P&S Intelligence
Published: 2021-03-16 (Crawled : 08:00) - prnewswire.com
TAK | News | $13.23 -1.12% 0.0% 920K
|
Health Technology
|
| O: 0.32%
H: 0.53%
C: -0.11%
NVS | News | $98.35 1.1% 0.69% 2.1M
|
Health Technology
|
| O: 0.14%
H: 0.82%
C: 0.7%
VCEL | $46.11 -0.67% -0.72% 200K
|
Health Technology
|
| O: 0.93%
H: 0.06%
C: -5.0%
IART | $29.38 -0.1% 900K
|
Health Technology
|
| O: 0.38%
H: 0.0%
C: -1.82%
AMGN | News | $273.01 -0.19% -0.17% 400
|
Health Technology
|
| O: 0.91%
H: 1.64%
C: 0.93%
Gainers vs Losers
| 61% | 39% |
Top 10 Gainers
BOF | $2.08 77.78% 39.06% 110M
|
BHIL | $0.1793 -4.37% 19.24% 340K
|
Agriculture, Forestry, Fishing ...
UMAC | $1.48 -1.33% 14.87% 20K
|
CI | $352.28 -0.11% 13.53% 2
|
Health Services
CIG.C | $2.89 -1.37% 12.8% 2.3K
|
n/a
MTH | $154.69 -2.21% 12.68% 450K
|
Consumer Durables
HCP | News | $31.41 7.75% 11.26% 1.2M
|
BMTX 4 | $1.545 0.98% 10.03% 2.5K
|
Information
TAL | $12.26 0.57% 9.22% 12M
|
Consumer Services
ASXC | $0.243 -2.41% 7.0% 1.1M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.